Effect of cabergoline monotherapy in Cushing ’s disease: an individual participant data meta-analysis

ConclusionsThis meta-analysis shows that cabergoline monotherapy is a reasonable alternative for subjects with persistent or recurrent CD after TSS. It can also be used in CD patients either as a bridge therapy while waiting for surgery or in those unwilling for surgery or have contraindication to it.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research